NMIH vs REGN
NMI Holdings Inc (NMIH) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
NMI Holdings Inc (NMIH) is a insurance - specialty company listed on US.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported NMIH revenue for 2024-12-31 was $651.0M. Net income was $360.1M. Revenue was up 12.4% from 2023-12-31 to 2024-12-31. NMIH currently screens at market cap $2.96B and trailing P/E 8.2.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
NMIH currently screens at market cap $2.96B and trailing P/E 8.2. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the NMIH and REGN stock pages for the full models.
Not investment advice.